You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Clindamycin phosphate; tretinoin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for clindamycin phosphate; tretinoin and what is the scope of patent protection?

Clindamycin phosphate; tretinoin is the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Encube, Solaris Pharma Corp, Almirall, and Bausch, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

Six suppliers are listed for this compound.

Recent Clinical Trials for clindamycin phosphate; tretinoin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2
Alphacait, LLCPhase 2
Zeichner, Joshua, M.D.Phase 4

See all clindamycin phosphate; tretinoin clinical trials

Pharmacology for clindamycin phosphate; tretinoin
Paragraph IV (Patent) Challenges for CLINDAMYCIN PHOSPHATE; TRETINOIN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZIANA Gel clindamycin phosphate; tretinoin 1.2%/0.025% 050802 1 2010-12-17

US Patents and Regulatory Information for clindamycin phosphate; tretinoin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Encube CLINDAMYCIN PHOSPHATE AND TRETINOIN clindamycin phosphate; tretinoin GEL;TOPICAL 216943-001 Sep 1, 2023 AB2 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solaris Pharma Corp CLINDAMYCIN PHOSPHATE AND TRETINOIN clindamycin phosphate; tretinoin GEL;TOPICAL 212845-001 Feb 10, 2022 AB2 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Mid Atlantic CLINDAMYCIN PHOSPHATE AND TRETINOIN clindamycin phosphate; tretinoin GEL;TOPICAL 202564-001 Jun 12, 2015 AB1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802-001 Nov 7, 2006 AB1 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Almirall VELTIN clindamycin phosphate; tretinoin GEL;TOPICAL 050803-001 Jul 16, 2010 AB2 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for clindamycin phosphate; tretinoin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802-001 Nov 7, 2006 ⤷  Sign Up ⤷  Sign Up
Almirall VELTIN clindamycin phosphate; tretinoin GEL;TOPICAL 050803-001 Jul 16, 2010 ⤷  Sign Up ⤷  Sign Up
Bausch ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802-001 Nov 7, 2006 ⤷  Sign Up ⤷  Sign Up
Bausch ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802-001 Nov 7, 2006 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.